ISRG
INTUITIVE SURGICAL INC
$440.62
-1.87%
$159.0B
No data for this timeframe.
Vol
Market Cap$159.0B
Cap SizeLarge Cap
Analyst ConsensusStrong Buy (71%)
Inst. Holders10 funds
Inst. Value$33.3B
Inst. Activity2 buys / 0 sells
Insider Activity0B / 11S
Insider Net $-$3.5M
Reddit Sentiment58° Warm
SEC Reports14
Congressional2 trades
Exchange Nasdaq·Sector Orthopedic, Prosthetic & Surgical Appliances & Supplies·Inc. DE·CIK 0001035267·Prev Close $449.03
Recent Activity
Jul 20, 2026
earnings_calendar
ISRG Q2 2026 Earnings After Market Close — 2026-07-20
EPS est: $2.53 | Rev est: $2.9B
May 21, 2026
Event
Samesurf, Inc. v. Intuit Inc.
Court ruling from Court of Appeals for the Federal Circuit. Docket: 24-2268
May 20, 2026
Insider
Brosius Mark sold 18 shares
EVP & Chief Mfg and Supply Cha @ $440.38 ($7.9K)
May 19, 2026
Insider
Brosius Mark sold 18 shares
EVP & Chief Mfg and Supply Cha @ $440.70 ($7.9K)
May 18, 2026
Insider
Brosius Mark sold 18 shares
EVP & Chief Mfg and Supply Cha @ $422.47 ($7.6K)
May 1, 2026
SEC
Citigroup upgrades ISRG to Buy from Neutral, PT $590 (+29%) — Part of a 10-firm cluster, but low-accuracy firm limits impact
ANALYST-UPGRADE — Impact 1/10
Apr 21, 2026
SEC
Intuitive Surgical reported Q1 2026 revenue of $2.77B (23% YoY growth) and non-GAAP EPS of $2.50, beating consensus esti
PRESS-RELEASE — Impact 8/10
Apr 21, 2026
SEC
Intuitive Surgical reported strong Q1 2026 results with revenue of $2.77 billion (23% YoY growth) and GAAP EPS of $2.28,
8-K — Impact 8/10
Price Targets
$572.68
+30.0% upside
Strong Buy
Current $440.62
Low $378.00
Median $578.50
High $750.00
30 analysts
$378.00
$750.00
Analyst Ratings
11Strong Buy
18Buy
11Hold
1Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 18, 2026 | B of A Securities | MAINTAIN | Buy → Buy |
| Apr 23, 2026 | Barclays | MAINTAIN | Overweight → Overweight |
| Apr 22, 2026 | Leerink Partners | MAINTAIN | Outperform → Outperform |
| Apr 22, 2026 | Baird | MAINTAIN | Outperform → Outperform |
| Apr 22, 2026 | Piper Sandler | MAINTAIN | Overweight → Overweight |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $2.50 ▲ +1.1% | $2.41 — $2.61 | 14% YoY | 25 |
| Next Q | $2.58 | $2.44 — $2.75 | 8% YoY | 25 |
| Current FY | $10.41 ▲ +4.1% | $10.14 — $10.76 | 17% YoY | 27 |
| Next FY | $11.79 ▲ +3.2% | $10.86 — $12.61 | 13% YoY | 28 |
Latest Reports
MIXED
ANALYST-UPGRADE
1/10
Citigroup upgrades ISRG to Buy from Neutral, PT $590 (+29%) — Part of a 10-firm cluster, but low-accuracy firm limits impact
May 1, 2026
BULLISH
PRESS-RELEASE
8/10
Intuitive Surgical reported Q1 2026 revenue of $2.77B (23% YoY growth) and non-GAAP EPS of $2.50, beating consensus esti
Apr 21, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $19.0B | — |
| FMR LLC | $3.7B | ADD |
| MORGAN STANLEY | $3.3B | — |
| NORGES BANK | $2.9B | NEW |
| BANK OF AMERICA CORP | $2.0B | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 20, 2026 | Brosius Mark | SELL | $7.9K |
| May 19, 2026 | Brosius Mark | SELL | $7.9K |
| May 18, 2026 | Brosius Mark | SELL | $7.6K |
| May 11, 2026 | LOEB GARY | SELL | $178.8K |
| Apr 30, 2026 | CHEW LEWIS | M | $0.00 |
Reddit Sentiment
58°
Warm
Bearish
Neutral
Bullish
Congressional Trades
2 members: 2 buys, 0 sells
| Member | Party | Type | Amount |
|---|---|---|---|
| Gilbert Cisneros | D | BUY | $1,001 - $15,000 |
| Markwayne Mullin | R | BUY | $15,001 - $50,000 |
10 institutional holders with $33.3B total value (58,732,165 shares) as of 2025-Q4. Top holders: VANGUARD, FMR, MORGAN. Net buying activity: 2 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 33,613,298 | $19.0B | 57.2% | — |
| 2 | FMR LLC | 6,577,517 | $3.7B | 11.2% | ADD +31.6% |
| 3 | MORGAN STANLEY | 5,741,035 | $3.3B | 9.8% | — |
| 4 | NORGES BANK | 5,044,472 | $2.9B | 8.6% | NEW |
| 5 | BANK OF AMERICA CORP /DE/ | 3,500,681 | $2.0B | 6.0% | — |
| 6 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,554,514 | $1.4B | 4.3% | NEW |
| 7 | WELLS FARGO & COMPANY/MN | 1,087,439 | $615.9M | 1.9% | — |
| 8 | TWO SIGMA INVESTMENTS, LP | 459,879 | $260.5M | 0.8% | ADD +37.5% |
| 9 | RENAISSANCE TECHNOLOGIES LLC | 152,830 | $86.6M | 0.3% | NEW |
| 10 | DODGE & COX | 500 | $283.2K | 0.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| FMR LLC | ADD | 4,999,960 | 6,577,517 | +31.6% | $3.7B | 2025-Q4 |
| NORGES BANK | NEW | — | 5,044,472 | — | $2.9B | 2025-Q4 |
| FMR LLC | TRIM | 8,659,892 | 4,999,960 | -42.3% | $2.2B | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | ADD | 400,871 | 551,017 | +37.5% | $246.4M | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 194,530 | — | $87.0M | 2025-Q3 |
| NORGES BANK | EXIT | 4,728,033 | 0 | -100.0% | $0.00 | 2025-Q3 |
| NORGES BANK | NEW | — | 4,728,033 | — | $2.6B | 2025-Q2 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 114,530 | 0 | -100.0% | $0.00 | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 68,310 | 411,661 | +502.6% | $203.9M | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 7,630 | 114,530 | +1401.0% | $56.7M | 2025-Q1 |
| NORGES BANK | EXIT | 4,600,913 | 0 | -100.0% | $0.00 | 2025-Q1 |
| CITADEL ADVISORS LLC | TRIM | 1,594,374 | 1,160,654 | -27.2% | $605.8M | 2024-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | NEAR_EXIT | 92,330 | 7,630 | -91.7% | $4.0M | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 2,227,467 | — | $1.1B | 2024-Q3 |
16 unique insiders with 11 transactions. Net insider value: -$3.5M ($0.00 bought, $3.5M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 20, 2026 | Brosius Mark | EVP & Chief Mfg and Supply Cha | SELL | 18 | $440.38 | $7.9K |
| May 19, 2026 | Brosius Mark | EVP & Chief Mfg and Supply Cha | SELL | 18 | $440.70 | $7.9K |
| May 18, 2026 | Brosius Mark | EVP & Chief Mfg and Supply Cha | SELL | 18 | $422.47 | $7.6K |
| May 11, 2026 | LOEB GARY | EVP & Chief Legal and Complian | SELL | 400 | $446.95 | $178.8K |
| Apr 30, 2026 | CHEW LEWIS | Director | M | 531 | $0.00 | $0.00 |
| Apr 30, 2026 | CHEW LEWIS | Director | M | 531 | $0.00 | $0.00 |
| Apr 30, 2026 | Ladd Amy L | Director | M | 531 | $0.00 | $0.00 |
| Apr 30, 2026 | CHEW LEWIS | Director | A | 554 | $0.00 | $0.00 |
| Apr 30, 2026 | Johnson Amal M | Director | M | 531 | $0.00 | $0.00 |
| Apr 30, 2026 | Johnson Amal M | Director | M | 531 | $0.00 | $0.00 |
| Apr 30, 2026 | Leonard Keith R | Director | M | 531 | $0.00 | $0.00 |
| Apr 30, 2026 | Leonard Keith R | Director | A | 554 | $0.00 | $0.00 |
| Apr 30, 2026 | NACHTSHEIM JAMI K | Director | M | 531 | $0.00 | $0.00 |
| Apr 30, 2026 | NACHTSHEIM JAMI K | Director | M | 531 | $0.00 | $0.00 |
| Apr 30, 2026 | NACHTSHEIM JAMI K | Director | A | 554 | $0.00 | $0.00 |
| Apr 30, 2026 | Kolli Sreelakshmi | Director | M | 531 | $0.00 | $0.00 |
| Apr 30, 2026 | Kolli Sreelakshmi | Director | M | 531 | $0.00 | $0.00 |
| Apr 30, 2026 | Kolli Sreelakshmi | Director | A | 554 | $0.00 | $0.00 |
| Apr 30, 2026 | GUTHART GARY S | Director | A | 554 | $0.00 | $0.00 |
| Apr 30, 2026 | Reed Monica P | Director | M | 531 | $0.00 | $0.00 |
| Apr 30, 2026 | Reed Monica P | Director | M | 531 | $0.00 | $0.00 |
| Apr 30, 2026 | Reed Monica P | Director | A | 554 | $0.00 | $0.00 |
| Apr 30, 2026 | BARRATT CRAIG H | Director | M | 750 | $0.00 | $0.00 |
| Apr 30, 2026 | BARRATT CRAIG H | Director | M | 750 | $0.00 | $0.00 |
| Apr 30, 2026 | BARRATT CRAIG H | Director | A | 643 | $0.00 | $0.00 |
| Apr 30, 2026 | Beery Joseph C | Director | M | 531 | $0.00 | $0.00 |
| Apr 30, 2026 | Beery Joseph C | Director | M | 531 | $0.00 | $0.00 |
| Apr 30, 2026 | Beery Joseph C | Director | A | 554 | $0.00 | $0.00 |
| Apr 30, 2026 | Ladd Amy L | Director | A | 554 | $0.00 | $0.00 |
| Apr 30, 2026 | Ladd Amy L | Director | M | 531 | $0.00 | $0.00 |
| Apr 30, 2026 | Leonard Keith R | Director | M | 531 | $0.00 | $0.00 |
| Apr 29, 2026 | Ladd Amy L | Director | SELL | 119 | $463.50 | $55.2K |
| Apr 28, 2026 | Ladd Amy L | Director | SELL | 500 | $473.46 | $236.7K |
| Mar 10, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | 105 | $229.39 | $24.1K |
| Mar 10, 2026 | Curet Myriam | EVP & Chief Medical Officer | SELL | 105 | $493.95 | $51.9K |
| Mar 10, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | 105 | $0.00 | $0.00 |
| Mar 9, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | SELL | 645 | $485.01 | $312.8K |
| Mar 6, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | SELL | 648 | $490.19 | $317.6K |
| Mar 3, 2026 | Widman Fredrik | VP Corporate Controller | SELL | 118 | $487.18 | $57.5K |
| Mar 3, 2026 | Curet Myriam | EVP & Chief Medical Officer | SELL | 4,728 | $487.18 | $2.3M |
| Mar 2, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | 125 | $208.90 | $26.1K |
| Mar 2, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | 125 | $0.00 | $0.00 |
| Feb 28, 2026 | Jeddi Iman | SVP & GM da Vinci Platforms & | M | 626 | $0.00 | $0.00 |
| Feb 28, 2026 | Brosius Mark | SVP & Chief Mfg and Supply Cha | M | 8,378 | $0.00 | $0.00 |
| Feb 28, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | 1,002 | $0.00 | $0.00 |
| Feb 28, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | 8,378 | $0.00 | $0.00 |
| Feb 28, 2026 | Curet Myriam | EVP & Chief Medical Officer | M | 1,002 | $0.00 | $0.00 |
| Feb 28, 2026 | LOEB GARY | EVP & Chief Legal and Complian | M | 3,148 | $0.00 | $0.00 |
| Feb 28, 2026 | Rosa David J. | Chief Executive Officer (CEO) | M | 1,503 | $0.00 | $0.00 |
| Feb 28, 2026 | Rosa David J. | Chief Executive Officer (CEO) | M | 14,363 | $0.00 | $0.00 |
14 SEC filing reports analyzed. Sentiment: 2 bullish, 2 bearish, 1 mixed, 9 neutral. Avg impact: 4.1/10.
MIXED
ANALYST-UPGRADE
1/10
Citigroup upgrades ISRG to Buy from Neutral, PT $590 (+29%) — Part of a 10-firm cluster, but low-accuracy firm limits impact
May 1, 2026
BULLISH
PRESS-RELEASE
8/10
Intuitive Surgical reported Q1 2026 revenue of $2.77B (23% YoY growth) and non-GAAP EPS of $2.50, be
Apr 21, 2026
BULLISH
8-K
8/10
Intuitive Surgical reported strong Q1 2026 results with revenue of $2.77 billion (23% YoY growth) an
Apr 21, 2026
NEUTRAL
COURT-RULING
2/10
A federal magistrate judge ruled that plaintiff John Yoon must travel to San Francisco, California f
Apr 21, 2026
NEUTRAL
DEFA14A
3/10
Analysis based on filing metadata only — document content was unavailable
Mar 13, 2026
BEARISH
CLUSTER
5/10
Two senior executives at Intuitive Surgical — EVP Myriam Curet and SVP Mark Brosius — sold shares in
Mar 11, 2026
NEUTRAL
CLUSTER
3/10
SVP and Chief Manufacturing and Supply Chain Officer Mark Brosius sold a total of 1,293 shares in tw
Mar 10, 2026
NEUTRAL
CLUSTER
4/10
Multiple Intuitive Surgical insiders, including the CEO, CFO, and other C-suite executives, exercise
Mar 3, 2026
BEARISH
CLUSTER
6/10
Intuitive Surgical insiders executed a cluster of 19 transactions over seven days, including two ope
Mar 3, 2026
NEUTRAL
CLUSTER
3/10
A cluster of insider transactions at Intuitive Surgical over the past seven days consists primarily
Mar 3, 2026
NEUTRAL
CLUSTER
3/10
A cluster of insider transactions at Intuitive Surgical over the past week consists primarily of non
Mar 3, 2026
NEUTRAL
CLUSTER
3/10
A cluster of insider transactions at Intuitive Surgical over the past seven days consists primarily
Mar 2, 2026
NEUTRAL
CLUSTER
4/10
Over the past seven days, seven executives at Intuitive Surgical exercised stock options totaling 15
Mar 2, 2026
NEUTRAL
CLUSTER
4/10
Intuitive Surgical insiders executed a cluster of derivative exercises and open-market sales over th
Mar 2, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Buy (71% buy). Based on 41 analysts: 11 strong buy, 18 buy, 11 hold, 1 sell, 0 strong sell.
Analyst Price Targets
$572.68 mean target
+30.0% upside
Strong Buy (1.91)
$378.00 Low
$750.00 High
| Metric | Value |
|---|---|
| Current Price | $440.62 |
| Target Low | $378.00 |
| Target Mean | $572.68 |
| Target Median | $578.50 |
| Target High | $750.00 |
| # Analysts | 30 |
| Recommendation | Strong Buy (1.91) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$2.50 | $2.41 | $2.61 | 14.3% | +1.1% | 15↑ 6↓ | $2.8B | 15.8% | 25 |
| Next Q 2026-09-30 |
$2.58 | $2.44 | $2.75 | 7.6% | +0.3% | 9↑ 11↓ | $2.9B | 15.5% | 25 |
| Current FY 2026-12-31 |
$10.41 | $10.14 | $10.76 | 16.6% | +4.1% | 25↑ 1↓ | $11.7B | 16.3% | 27 |
| Next FY 2027-12-31 |
$11.79 | $10.86 | $12.61 | 13.2% | +3.2% | 26↑ 0↓ | $13.3B | 13.3% | 28 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $2.503 | |
| 7d ago | $2.503 | |
| 30d ago | $2.474 | +0.028 |
| 60d ago | $2.482 | +0.021 |
| 90d ago | $2.477 | +0.026 |
17 analyst firms have rated this stock: 3 upgrades, 1 downgrades, 1 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 18, 2026 | B of A Securities | MAINTAIN | Buy | Buy |
| Apr 23, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| Apr 22, 2026 | Leerink Partners | MAINTAIN | Outperform | Outperform |
| Apr 22, 2026 | Baird | MAINTAIN | Outperform | Outperform |
| Apr 22, 2026 | Piper Sandler | MAINTAIN | Overweight | Overweight |
| Apr 22, 2026 | BTIG | REITERATE | Buy | Buy |
| Apr 15, 2026 | Truist Securities | MAINTAIN | Buy | Buy |
| Apr 13, 2026 | Mizuho | MAINTAIN | Neutral | Neutral |
| Apr 10, 2026 | BTIG | REITERATE | Buy | Buy |
| Apr 9, 2026 | Goldman Sachs | MAINTAIN | Buy | Buy |
| Apr 6, 2026 | Evercore ISI Group | MAINTAIN | In-Line | In-Line |
| Mar 17, 2026 | UBS | MAINTAIN | Neutral | Neutral |
| Mar 11, 2026 | Citigroup | UPGRADE | Neutral | Buy |
| Feb 24, 2026 | UBS | MAINTAIN | Neutral | Neutral |
| Jan 27, 2026 | Freedom Capital Markets | UPGRADE | Hold | Buy |
| Jan 27, 2026 | TD Cowen | INITIATE | — | Buy |
| Jan 26, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| Jan 26, 2026 | Freedom Broker | UPGRADE | Hold | Buy |
| Jan 23, 2026 | Citigroup | MAINTAIN | Neutral | Neutral |
| Jan 23, 2026 | Evercore ISI Group | MAINTAIN | In-Line | In-Line |
| Jan 23, 2026 | Piper Sandler | MAINTAIN | Overweight | Overweight |
| Jan 23, 2026 | Bernstein | MAINTAIN | Outperform | Outperform |
| Jan 23, 2026 | BTIG | REITERATE | Buy | Buy |
| Jan 9, 2026 | Bernstein | MAINTAIN | Outperform | Outperform |
| Jan 7, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| Jan 7, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Dec 18, 2025 | Truist Securities | MAINTAIN | Buy | Buy |
| Dec 17, 2025 | RBC Capital | MAINTAIN | Outperform | Outperform |
| Dec 11, 2025 | Citigroup | DOWNGRADE | Buy | Neutral |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | 11 | 18 | 11 | 1 | 0 | 71% | |
| Apr 1, 2026 | 11 | 18 | 11 | 1 | 0 | 71% | |
| Mar 1, 2026 | 10 | 19 | 12 | 1 | 0 | 69% | |
| Feb 1, 2026 | 10 | 19 | 12 | 1 | 0 | 69% | |
| Jan 1, 2026 | 10 | 15 | 14 | 1 | 0 | 63% | |
| Dec 1, 2025 | 11 | 15 | 13 | 1 | 0 | 65% | |
| Nov 1, 2025 | 12 | 15 | 13 | 1 | 0 | 66% |
Strong BuyBuyHoldSellStrong Sell
2 members of Congress traded this stock: 2 buys, 0 sells.
Congressional Trades
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | Gilbert Cisneros | D | HOUSE | BUY | $1,001 - $15,000 | Intuitive Surgical Inc | Feb 16, 2026 (18d) |
| Dec 29, 2025 | Markwayne Mullin | R | SENATE | BUY | $15,001 - $50,000 | Intuitive Surgical Inc | Jan 16, 2026 (19d) |
58°
Warm
Bearish
Neutral
Bullish
9 mentions
2 bullish
0 bearish
6 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Apr 21, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Apr 20, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Apr 20, 2026 | 2 | 58° Warm | 1 | 0 | 2 |
| Apr 20, 2026 | 2 | 58° Warm | 1 | 0 | 2 |
| Mar 13, 2026 | 2 | 50° Neutral | 0 | 0 | 2 |
| Mar 13, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
Recent Reddit Threads
ISRG vs AMZN for monthly DCA
▲ 1
💬 1
⚡ 0.5
ISRG - Intuitive Surgical will have a down week
▲ 1
💬 1
⚡ 0.5
ISRG - BUY PUTS
▲ 1
💬 0
⚡ 0.5
VICR, ISRG, IBKR - reporting tomorrow.
▲ 1
💬 1
⚡ 0.5
ISRG REPORTS TUESDAY. BE PREPARED
▲ 1
💬 0
⚡ 0.5
ISRG BUY PUTS
▲ 1
💬 0
⚡ 0.5
ISRG vs AMZN for monthly DCA
▲ 1
💬 0
⚡ 0.5
Jul 20, 2026
earnings_calendar
ISRG Q2 2026 Earnings After Market Close — 2026-07-20
EPS est: $2.53 | Rev est: $2.9B
May 21, 2026
other
Intuitive Announces Innovations to Advance Quintuple Aim
Latest innovations include enhanced telecollaboration capabilities, extended uses for Force Feedback technology, and advancements in product and instr
May 21, 2026
Enforcement
Samesurf, Inc. v. Intuit Inc.
Court ruling from Court of Appeals for the Federal Circuit. Docket: 24-2268
Apr 27, 2026
short_volume
Short Volume: ISRG — 55.5% short (0.4M / 0.7M)
Short: 391,232 | Exempt: 15,341 | TRF Vol: 704,995 | Short Ratio: 55.5% | Off-exchange volume (dark pool + OTC)
Apr 27, 2026
dark_pool
Dark Pool: ISRG — 2.3M shares, 87,648 trades
Week starting 2026-04-27. Total ATS volume: 2,291,781 shares across 87,648 trades.
Apr 24, 2026
short_volume
Short Volume: ISRG — 58.0% short (0.6M / 1.1M)
Short: 628,485 | Exempt: 33,450 | TRF Vol: 1,083,583 | Short Ratio: 58.0% | Off-exchange volume (dark pool + OTC)
Apr 21, 2026
earnings
Intuitive Announces First Quarter Earnings
<p align="justify">SUNNYVALE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in min
Apr 21, 2026
earnings_calendar
ISRG Q1 2026 Earnings After Market Close — 2026-04-21
EPS est: $2.16 | Rev est: $2.7B
Apr 21, 2026
earnings_calendar
ISRG Q1 2026 Earnings After Market Close — 2026-04-21
Apr 21, 2026
short_volume
Short Volume: ISRG — 58.7% short (0.6M / 1.1M)
Short: 639,026 | Exempt: 589 | TRF Vol: 1,088,174 | Short Ratio: 58.7% | Off-exchange volume (dark pool + OTC)
Apr 20, 2026
dark_pool
Dark Pool: ISRG — 4.3M shares, 131,108 trades
Week starting 2026-04-20. Total ATS volume: 4,259,755 shares across 131,108 trades.
Apr 14, 2026
short_volume
Short Volume: ISRG — 59.6% short (0.4M / 0.7M)
Short: 445,983 | Exempt: 143 | TRF Vol: 747,757 | Short Ratio: 59.6% | Off-exchange volume (dark pool + OTC)
Apr 13, 2026
dark_pool
Dark Pool: ISRG — 3.0M shares, 92,205 trades
Week starting 2026-04-13. Total ATS volume: 2,987,661 shares across 92,205 trades.
Apr 10, 2026
short_interest
FTD: ISRG — 2,412 shares ($1.1M) failed to deliver
Settlement: 20260410, Price: $454.94, FTD Value: $1,097,315.28, INTUITIVE SURGICAL INC
Apr 7, 2026
Enforcement
Intuit Inc. v. Samesurf, Inc.
Court ruling from Court of Appeals for the Federal Circuit. Docket: 24-2298
Apr 6, 2026
dark_pool
Dark Pool: ISRG — 2.3M shares, 88,183 trades
Week starting 2026-04-06. Total ATS volume: 2,322,281 shares across 88,183 trades.
Apr 1, 2026
short_volume
Short Volume: ISRG — 57.3% short (0.3M / 0.6M)
Short: 341,281 | Exempt: 157 | TRF Vol: 596,015 | Short Ratio: 57.3% | Off-exchange volume (dark pool + OTC)
Mar 20, 2026
Enforcement
Intuit v. FTC
Court ruling from Court of Appeals for the Fifth Circuit. Docket: 24-60040
Jan 20, 2026
Enforcement
John Yoon v. Intuit Inc.
Court ruling from District Court, N.D. California. Docket: 5:25-cv-03469